ResMed (RMD) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $228.42 +0.07%
EPS Growth %: +5.5%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +5.5%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $1.49, $0.04 better than the analyst estimate of $1.45. Revenue for the quarter came in at $914.7 million versus the consensus estimate of $910.54 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- ResMed (RMD) call put ratio 1.5 calls to 1 put as share price up 4.3%
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
